The next 25 years of cancer research: emerging perspectives and priorities
Myriam Chalabi, Tim Coorens, Leanne Li, James L. Reading et autres
0 citationsNature reviews. Cancer
Myriam Chalabi
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
100Publications signalées
8040Citations signalées
3Affiliations récentes
Institutions déclarées
Domaines associés
Cancer Immunotherapy and BiomarkersColorectal Cancer Treatments and StudiesGenetic factors in colorectal cancerColorectal Cancer Surgical TreatmentsGastric Cancer Management and Outcomes
Publications récentes
A real-world analysis of metastasectomy in patients with small intestinal adenocarcinoma presenting with metastasized disease
Pascale Schafrat, Demy Danielsson, Felice N. van Erning, Rutger‐Jan Swijnenburg et autres
0 citationsEuropean Journal of Surgical Oncology
Perioperative systemic therapy versus surgery alone for resectable colorectal peritoneal-only metastases (CAIRO6): a randomised, open-label, phase 3 trial
Koen P. Rovers, Checca Bakkers, Teun B M van den Heuvel, Vincent C J van de Vlasakker et autres
0 citationsThe Lancet Oncology
Prognostic significance of CK7, CK20, and CDX2 expression in small intestinal adenocarcinoma
Pascale Schafrat, J.D.G. Linssen, Tim R. de Back, L.E. Nijman et autres
0 citationsESMO Gastrointestinal Oncology
Symbiotic-GI-03: A randomized, double-blind, phase 3 study of first-line PF-08634404, a PD-1/VEGF bispecific antibody, in combination with mFOLFOX6 in patients with metastatic colorectal cancer (mCRC).
Cathy Eng, E Elez, Julien Taieb, Rui-Hua Xu et autres
0 citationsJournal of Clinical Oncology
Association of progression-free survival (PFS) with microsatellite instability–high (MSI-H) or mismatch repair–deficient (dMMR) status determined by single vs dual validated companion diagnostic (CDx) assays: CheckMate-8HW post hoc analyses.
Thierry Andre, Sara Lonardi, E Elez, Eric Van Cutsem et autres
0 citationsJournal of Clinical Oncology
Making sense of TILs : recommendations for morphological assessment of tumour‐infiltrating lymphocytes in gastro‐oesophageal carcinoma
Ylva Weeda, R. Salgado, Filip Van Herpe, Daniel Sur et autres
0 citationsHistopathology
Diagnosis and treatment of human epidermal growth factor receptor 2-positive metastatic colorectal cancer: a systematic literature review
Salvatore Siena, Myriam Chalabi, Rachel Goodwin, Pia Österlund et autres
2 citationsCancer Treatment Reviews
Surgical journey for participants (pts) in the MATTERHORN trial: A global, randomized, phase 3 study of durvalumab (D) plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric/gastroesophageal junction (G/GEJ) adenocarcinoma.
D. Molena, Woo Jin Hyung, Zev A. Wainberg, M. Liberman et autres
1 citationJournal of Clinical Oncology
Clinical utility of the Idylla CDx MSI test in identifying MSI-H mCRC patients eligible for nivolumab monotherapy or in combination with ipilimumab therapy (CheckMate 8HW phase III trial).
Thierry Andre, SARA LONARDI, David S. Yu, Chelsea Jin et autres
1 citationJournal of Clinical Oncology
KEYSTEP-008: Pembrolizumab (pembro)-based combinations for microsatellite instability-high (MSI-H)/mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC).
Thierry Andre, Filippo Pietrantonio, S. Yalcin, Joong Bae Ahn et autres
0 citationsJournal of Clinical Oncology
Early successes in colon immunotherapy
0 citationsNature Medicine
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.